» Drug, Devices, and Supplements

» Physician Accountability

» Consumer Product Safety

» Worker Safety

» Health Care Delivery

» Auto and Truck Safety

» Global Access to Medicines

» Infant Formula Marketing


Letter to CMS Supporting Proposed Decision to Severely Restrict Coverage for β-Amyloid PET Imaging in Dementia

July 23, 2013

View as PDF.

Public Citizen strongly supports the Centers for Medicare & Medicaid Services’ (CMS’s) proposed decision to only cover positron emission tomography (PET) amyloid-beta (Aβ) imaging in dementia and neurodegenerative disease for a limited set of circumstances. There is insufficient clinical-trial data to support that this technology changes the health outcomes of patients who display early symptoms or signs of cognitive dysfunction, or in any other patient population.

Copyright © 2017 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.

Public Citizen, Inc. and Public Citizen Foundation


You can support the fight for greater government and corporate accountability through a donation to either Public Citizen, Inc., or Public Citizen Foundation, Inc.

Public Citizen lobbies Congress and federal agencies to advance Public Citizen’s mission of advancing government and corporate accountability. When you make a contribution to Public Citizen, you become a member of Public Citizen, showing your support and entitling you to benefits such as Public Citizen News. Contributions to Public Citizen are not tax-deductible.

Public Citizen Foundation focuses on research, public education, and litigation in support of our mission. By law, the Foundation can engage in only very limited lobbying. Contributions to Public Citizen Foundation are tax-deductible.